Impact of endocrine disruptors on key events of hepatic steatosis in HepG2 cells
Food and Chemical Toxicology · 2025
DOI: 10.1016/j.fct.2025.115241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2025. Verfasst von Marina F Grosso und 5 weiteren Autor:innen. Beteiligte Einrichtung: RECETOX, Faculty of Science, Masaryk University, Kotlářská 2, 61137, Brno, Czech Republic. Hauptthemen laut MEDLINE: Endocrine Disruptors, Fatty Liver. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Horizon 2020, Masaryk University, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
Endocrine-disrupting chemicals (EDCs) may contribute to the rising incidence of metabolic dysfunction-associated steatotic liver disease (MASLD). We investigated the potential of 10 environmentally relevant EDCs to affect key events of hepatic steatosis in HepG2 human hepatoblastoma cells. Increased lipid droplet formation, a key marker of steatosis, was induced by PFOA, bisphenol F, DDE, butylparaben, and DEHP, within the non-cytotoxic concentration range of 1 nM-25 μM. Cadmium also induced this effect, but at concentrations impairing cell viability (>1 μM). At non-cytotoxic concentrations, these compounds, along with bisphenol A, dysregulated major genes controlling lipid homeostasis. Cadmium, PFOA, DDE, and DEHP significantly upregulated the DGAT1 gene involved in triglyceride synthesis, while butylparaben increased the expression of the FAT/CD36 gene responsible for fatty acid uptake. Bisphenol A downregulated the CPT1A gene involved in fatty acid oxidation. No significant effects on lipid droplet accumulation or lipid metabolism-related genes were observed for PFOS, bisphenol S, and dibutyl phthalate. Among the tested EDCs, lipid accumulation positively correlated with the expression of SREBF1, DGAT1, and CPT1A. These findings provide additional evidence that EDCs can affect MASLD and highlight the utility of in vitro methods in the screening of EDCs with hazardous steatogenic and metabolism-disrupting properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- RECETOX, Faculty of Science, Masaryk University, Kotlářská 2, 61137, Brno, Czech Republic.
- RECETOX, Faculty of Science, Masaryk University, Kotlářská 2, 61137, Brno, Czech Republic. Electronic address: pavel.babica@recetox.muni.cz.
Förderung
- Horizon 2020
- Masaryk University
- Horizon 2020 Framework Programme
- Bonneville Power Administration
- European Commission
- Ministry of Education Youth and Sports of the Czech Republic
Zitieren
APA
Grosso, M. F., Řehůřková, E., Virmani, I., Sychrová, E., Sovadinová, I., & Babica, P. (2025). Impact of endocrine disruptors on key events of hepatic steatosis in HepG2 cells. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2025.115241
Vancouver
Grosso MF, Řehůřková E, Virmani I, Sychrová E, Sovadinová I, Babica P. Impact of endocrine disruptors on key events of hepatic steatosis in HepG2 cells. Food and Chemical Toxicology. 2025. doi:10.1016/j.fct.2025.115241
BibTeX
@article{Grosso2025,
author = {Grosso, Marina F and Řehůřková, Eliška and Virmani, Ishita and Sychrová, Eliška and Sovadinová, Iva and Babica, Pavel},
title = {Impact of endocrine disruptors on key events of hepatic steatosis in HepG2 cells},
journal = {Food and Chemical Toxicology},
year = {2025},
doi = {10.1016/j.fct.2025.115241}
}
EUVIMED